Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus
about
Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesisEsophageal cancer: Recent advances in screening, targeted therapy, and managementUpper gastrointestinal microbiota and digestive diseasesEsophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk FactorsThe tumor microenvironment in esophageal cancerIntratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.Microbiome in reflux disorders and esophageal adenocarcinoma.Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling.The impact of proton pump inhibitors on the human gastrointestinal microbiomeShrinkage of the human core microbiome and a proposal for launching microbiome biobanks.Squamous tissue lymphocytes in the esophagus of controls and patients with reflux esophagitis and Barrett's esophagus are characterized by a non-inflammatory phenotype.Cancer and the microbiome: potential applications as new tumor biomarker.Rebamipide Alters the Esophageal Microbiome and Reduces the Incidence of Barrett's Esophagus in a Rat Model.Esophageal microbiome in eosinophilic esophagitis.Significance of paneth cell metaplasia in Barrett esophagus: a morphologic and clinicopathologic studyMicrobiome and potential targets for chemoprevention of esophageal adenocarcinoma.Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancerThe Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease.Diet and upper gastrointestinal cancers: in search of dark matterGastrointestinal malignancy and the microbiome.Toll-like receptors in esophageal cancer.The esophageal microbiota in health and disease.Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression.Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.The effect of n-3/n-6 polyunsaturated fatty acids on acute reflux esophagitis in rats.Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia.Infection and esophageal cancer.Emerging Insights into the Esophageal Microbiome.Co-upregulation of Toll-like receptors 2 and 6 on peripheral blood cells in patients with obstructive sleep apnea.Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders: A Clinical Perspective.Human Gut Microbiota and Gastrointestinal Cancer.Barrett's esophagus is associated with a distinct oral microbiome.Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications.
P2860
Q26766641-25541910-C030-42DA-A771-34FE1E2E09B9Q26865552-DA2F93B2-7765-4FE1-81EC-CB8CDBD44DA4Q27002380-1B35ABA6-0D0A-4E38-89D2-02B7B39C8447Q28076178-30159EB8-0C06-4EED-A0CC-3CDC51DD8E45Q28077074-1C9727A0-1D83-45DA-9F32-893236D39684Q33618507-5BFCF9CF-6570-41C5-B5D6-BA5AE7CF6C8FQ33997813-8FA226B3-F530-42B4-98F9-9A8652C14830Q34585721-5E12DB3E-8000-474A-9B19-1EF7D3ED562EQ34625008-7D09183B-CCA0-4FF1-B3F7-44A3D5C513C2Q35193531-959D2430-92FD-4070-8545-716D82DED959Q35234836-05E2949B-982A-47D7-9319-85D88CF7B54CQ35508820-2C624E31-1100-476E-97D5-5DB41E73340EQ35599452-885F764D-62B7-4300-9F4E-25D6E8308A80Q35644767-CCB874F6-D1A5-4786-9B25-0358FD40DAF7Q35856606-86E0B058-52FE-421B-BDCE-F4265B23961BQ35954977-7CD3B4BA-0F8B-427C-9CDF-F6743C30EB30Q36475989-30161209-E741-4A56-9AA3-B752E280D02AQ36751990-E07C781D-BE61-4F4F-AF4C-91545228ED0CQ37195141-76402E4F-DE9E-42D0-BE19-949A3B1D68C3Q37716976-15B5EA25-0272-4A4A-8F02-0D6D323171D4Q38213392-9C827537-DA86-40EF-8E02-B84F6AE980CBQ38896455-55749258-8632-4EBA-8DCA-DAE2A3955A1EQ39108713-C1E1AFCD-784A-4EB2-8118-F02F1E4F8FAEQ40537150-1A2CA44B-42FE-4911-B001-F801EC0E439AQ41326403-F84E2A22-590D-4AD1-BF68-9798DA6B2D8DQ42448630-7DAB6F44-E8C7-49C6-BB17-658FBB9AE0F6Q46832472-4C6E8E7B-A80F-4367-80EA-BB443AA3AB81Q47723798-7C57EE2A-EDC4-4F81-B9C4-C4C8C756B2D8Q48000023-8034C8FB-AACB-45A5-BB87-CB1FFF113791Q52312388-12EB768E-4C84-4C1B-9E3D-49E4DB240798Q52374120-78EECDF8-1417-442E-B4FC-2A028A435CDBQ52680706-A55F6AC6-C290-467E-9412-99814F003B21Q55243343-470C7170-DBFD-4733-963F-4BB8FBE1B3DA
P2860
Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular pathways: pathogenes ...... phagitis and Barrett esophagus
@en
Molecular pathways: pathogenes ...... hagitis and Barrett esophagus.
@nl
type
label
Molecular pathways: pathogenes ...... phagitis and Barrett esophagus
@en
Molecular pathways: pathogenes ...... hagitis and Barrett esophagus.
@nl
prefLabel
Molecular pathways: pathogenes ...... phagitis and Barrett esophagus
@en
Molecular pathways: pathogenes ...... hagitis and Barrett esophagus.
@nl
P2860
P50
P1476
Molecular pathways: pathogenes ...... phagitis and Barrett esophagus
@en
P2093
Fritz Francois
Liying Yang
P2860
P304
P356
10.1158/1078-0432.CCR-11-0934
P407
P577
2012-02-16T00:00:00Z